Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade - CCR5 relatedBlockade of the Programmed Death 1 (PD-1)/PD-1 Ligand (PD-L1) immune checkpoint axis with monoclonal antibodies is now a widespread therapeutic strategy User Thorilium, in the advancingleronlimab subreddit, 30 Sep 2022